Covered recipient · General Payments record
DEBORAH CAMISCOLI
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2021
$890.88
- Reported across 66 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $159.73 | 11 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $41.54 | 3 |
| ABBVIE INC. | $31.52 | 2 |
| GlaxoSmithKline, LLC. | $28.16 | 2 |
| Biohaven Pharmaceuticals, Inc. | $14.99 | 1 |
| Acerta Pharma LLC | $14.87 | 1 |
| Amarin Pharma Inc. | $14.71 | 1 |
| Genentech USA, Inc. | $13.94 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $16.65 | 05/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794205865 | CMS |
| AbbVie Inc. | $14.87 | 06/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794205867 | CMS |
| Amarin Pharma Inc. | $14.71 | 04/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 815411113 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.87 | 01/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | 830145903 | CMS |
| Biohaven Pharmaceuticals, Inc. | $14.99 | 06/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | 852447863 | CMS |
| Daiichi Sankyo Inc. | $11.51 | 01/20/2021 | Food and Beverage | Undisputed | 01/23/2026 | 836250235 | CMS |
| Daiichi Sankyo Inc. | $16.54 | 03/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 836274687 | CMS |
| Daiichi Sankyo Inc. | $13.49 | 06/20/2021 | Food and Beverage | Undisputed | 01/23/2026 | 836298661 | CMS |
| Genentech USA, Inc. | $13.94 | 01/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 835904369 | CMS |
| GlaxoSmithKline, LLC. | $14.77 | 01/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | 802666197 | CMS |
| GlaxoSmithKline, LLC. | $13.39 | 03/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 803178975 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.